Her investigation included angiogram and echo which basically showed severe aortic stenosis with calcified tricuspid aortic valve and significant disease in the right coronary artery and also a patent foramen ovale and mild mitral regurgitation.
CN III-XII in tact  Pertinent Results: [**2117-9-3**] 03:13AM BLOOD WBC-12.1* RBC-3.65* Hgb-11.1* Hct-33.8* MCV-93 MCH-30.5 MCHC-32.9 RDW-14.6 Plt Ct-272 [**2117-9-3**] 03:13AM BLOOD Glucose-104 UreaN-45* Creat-1.1 Na-146* K-4.5 Cl-105 HCO3-32 AnGap-14 [**2117-8-28**] 03:37AM BLOOD ALT-119* AST-155* LD(LDH)-368* AlkPhos-198* Amylase-51 TotBili-4.5* [**2117-9-3**] 03:13AM BLOOD Calcium-8.7 Phos-2.2* Mg-2.3 [**2117-8-16**] 01:20PM BLOOD %HbA1c-5.3 [Hgb]-DONE [A1c]-DONE [**2117-8-18**] 06:43AM BLOOD TSH-7.5* [**2117-8-27**] 04:46PM BLOOD Cortsol-38.5* [**2117-9-1**] 11:48AM BLOOD Type-ART pO2-141* pCO2-41 pH-7.50* calHCO3-33* Base XS-8  CXR [**2117-8-16**] 1.
Although these findings could be due to prior granulomatous disease, further evaluation is necessary.
If no prior studies are available, non-contrast CT of the chest is recommended.
[**2117-8-31**] CXR Comparison with [**2117-8-30**].
Findings were discussed with [**First Name8 (NamePattern2) **] [**Doctor Last Name **] at approximately 7:30 p.m., [**2117-8-31**]  [**2117-8-25**] EKG A-V paced rhythm Since previous tracing of [**2117-8-24**], paced rhythm now present  [**2117-8-22**] Head CT 1.
No evidence of [**Doctor Last Name 352**]-white differentiation to suggest a large minor or major vascular territorial infarct is identified, although MR is a more sensitive evaluation for evaluation for acute infarct.
[**2117-9-8**] 02:34AM BLOOD WBC-10.1 RBC-3.48* Hgb-10.5* Hct-31.1* MCV-89 MCH-30.0 MCHC-33.6 RDW-15.7* Plt Ct-243 [**2117-9-8**] 02:34AM BLOOD Plt Ct-243 [**2117-9-8**] 02:34AM BLOOD PT-18.9* PTT-32.9 INR(PT)-2.4 [**2117-9-8**] 02:34AM BLOOD Glucose-76 UreaN-29* Creat-0.9 Na-134 K-4.2 Cl-101 HCO3-26 AnGap-11 [**2117-9-5**] 02:00AM BLOOD ALT-71* AST-82* AlkPhos-206* Amylase-92 TotBili-1.6* [**2117-9-5**] 07:40PM BLOOD LD(LDH)-330* TotBili-1.6* DirBili-0.9* IndBili-0.7 [**2117-9-5**] 02:00AM BLOOD Lipase-118* [**2117-9-8**] 02:34AM BLOOD Calcium-8.6 Phos-2.4* Mg-1.8  [**Last Name (NamePattern4) 4125**]ospital Course: Mrs. [**Known lastname **] was admitted to the [**Hospital1 18**] on [**2117-8-17**] and taken directly to the operating room where she underwent an aortic valve replacement and an atrial septal defect closure.
A head CT scan was obtained which showed small areas of hypodensity within the left frontal lobe and right frontoparietal region, as well as within the subcortical white matter and corona radiata bilaterally.
A bronchoscopy was later performed which did not reveal significant secretions.
As she had not tolerated a passe muir valve, a bedside swallowing evaluation was defferred and a PEG feeding tube was recommended.
CVL was discontinued on [**9-8**] and INR was therapeutic [**Company 57359**] 98.0, 95/46, V paced at 81, RR 30 SIMV, 5 peep, 10 pressure support, 40%, alert, awake and comfortable.
Acetaminophen 160 mg/5 mL Solution Sig: One (1) Solution PO Q4H (every 4 hours) as needed for temperature >38.0.
Docusate Sodium 150 mg/15 mL Liquid Sig: Ten (10) ml PO BID (2 times a day).
Zetia 10 mg po daily   Discharge Disposition: Extended Care  Facility: [**Hospital3 7**] & Rehab Center - [**Hospital1 8**]  Discharge Diagnosis: Aortic stenosis PFO COPD Respiratory Failure CVA Hyperlipidemia Hypertension Peripheral vascular disease Permenant Pacemaker insitu s/p RLL stage IIIB lung ca with XRT   Discharge Condition: Stable  Discharge Instructions: 1) Monitor wounds for signs of infection.
